Document is current
Any future updates will be listed below
-
Authors
Bergdal, Rebecka https://orcid.org/0009-0000-0225-2947
Harjutsalo, Valma https://orcid.org/0000-0003-3568-9779
Groop, Per-Henrik https://orcid.org/0000-0003-4055-6954
Mutter, Stefan https://orcid.org/0000-0002-8293-6982
,
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 24 May 2025
First Online: 13 June 2025
Declarations
:
: The study protocol was approved by the Ethics Committee of the Helsinki and Uusimaa Health District, and the study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from each participant.
: Not applicable.
: P–HG reports receiving lecture honorariums from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elo Water, Medscape, MSD, Mundipharma, Novo Nordisk, PeerVoice, Sanofi, Sciarc, and being an advisory board member of AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Medscape, MSD, Mundipharma, Nestlé, Novo Nordisk, and Sanofi. SM reports receiving lecture honorarium from Encore Medical Education. All other authors declare no conflict of interest.
